Remove BMI Remove Public Health Remove Stroke
article thumbnail

Research highlights disparities in heart disease, stroke trends worldwide

Medical Xpress - Cardiology

Incidence of stroke and ischemic heart disease are declining around the world, except for in a handful of regions, according to research in PLOS Global Public Health.

article thumbnail

Abstract WP269: Predicting post-stroke all-cause dementia incidence using machine learning models and electronic health record data

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWP269-AWP269, February 1, 2025. Introduction:All-cause dementia remains a significant public health concern, with stroke recognized as a key risk factor. This study included patients aged 20+ who experienced their first stroke (any type) in 2018 (baseline). aged 20-44, 37.2%

article thumbnail

Global Trends in Cardiovascular Diseases: Insights from the 2023 Almanac

Cardiology Update

Metabolic risks, including high systolic blood pressure, high LDL cholesterol, high BMI, high fasting plasma glucose, and kidney dysfunction, contribute substantially to age-standardized CVD disability-adjusted life years (DALYs). The findings have significant implications for clinical and public health practice and research.

article thumbnail

Smoking Cannabis Associated with Increased Risk of Heart Attack, Stroke

DAIC

Getty Images milla1cf Tue, 03/05/2024 - 13:15 March 5, 2024 — Frequent cannabis smoking may significantly increase a person’s risk for heart attack and stroke, according to an observational study supported by the National Institutes of Health. Less frequent use was also associated with an increased risk of cardiovascular events.

article thumbnail

Abstract WMP101: Global Burden of Stroke Attributable to High BMI in 38 OECD Countries From 1990-2019: A Benchmarking Systematic Analysis

Stroke Journal

Stroke, Volume 55, Issue Suppl_1 , Page AWMP101-AWMP101, February 1, 2024. Conclusion:The global burden of stroke attributable to high BMI in OECD countries highlights the urgent need for comprehensive strategies to address the intertwined challenges of obesity and stroke.

BMI 40
article thumbnail

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

DAIC

Food and Drug Administration ( FDA ) has approved an additional indication for Wegovy ( semaglutide ) to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet and increased physical activity.

Obesity 111